Luoxin Pharmaceutical (002793): P-CAB Tigorasen approved to consolidate its leading position in the digestive tract
Luo Xin Pharmaceutical (002793) 2020 Third Quarterly Report Review: Q3 Performance Improved Month-on-Year, Focus on BD Varieties Contributing to Performance Elasticity
Luo Xin Pharmaceutical (002793): Exploring the reasonable value of the company under imitation and upgrading
Dongyin Co., Ltd. (002793) 2018 Annual Report Review: Annual Performance Slows and Fundraising Project Investment Implementation
Dongyin Co., Ltd. (002793) third quarter report review: Profitability recovery in the third quarter awaits market development
Dongyin shares (002793) semi-annual report comments: the first half of the performance slowed down in the second quarter profitability rebounded slightly
Dongyin Co., Ltd. (002793) depth report: handling of groundwater
Dongyin shares (002793) in the newspaper comments: domestic business share to enhance the continuous expansion of independent brands
[Huaxin Securities] Dongyin shares: Wang Qingquan, immortal
Dongyin Co., Ltd. (002793) In-depth Report: One Wang Qingquan Fangfang
[Huaxin Securities] Dongyin shares: Wang Qingquan, immortal
东音股份(002793)新股研究:国内潜水泵业领先者
【海通证券】东音股份新股研究报告:国内潜水泵业领先者